ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,043Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 46

$304K Total Retail Price of All Prescriptions

Rank: 19 out of 46

243 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 243 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 243 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 4,967 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 200 173 1 4
HYDROCODONE-ACETAMINOPHEN 193 125 S3 2 1
FUROSEMIDE 170 167 3 7
LISINOPRIL 168 149 4 3
WARFARIN SODIUM 163 162 5 13
OMEPRAZOLE 158 118 6 5
SIMVASTATIN 147 91 7 6
FLUOXETINE HCL 141 106 8 50
CARVEDILOL 119 107 9 29
TRIAMTERENE-HCTZ 118 97 10 64
METFORMIN HCL 93 74 11 9
LANTUS SOLOSTAR 89 57 12 145
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 49 13 27
POTASSIUM CHLORIDE 82 82 14 15
METFORMIN HCL ER 78 55 15 97
METOPROLOL TARTRATE 76 56 16 10
AZITHROMYCIN 74 60 17 30
PREDNISONE 73 59 18 51
LOVASTATIN 72 56 19 53
AMLODIPINE BESYLATE 69 44 20 8
ALLOPURINOL 60 41 21 40
DIGOXIN 60 60 21 80
DICLOFENAC SODIUM 59 37 23 135
CLOPIDOGREL 59 59 23 48
PRAVASTATIN SODIUM 58 48 25 12
RANITIDINE HCL 58 50 25 26
ISOSORBIDE MONONITRATE ER 57 56 27 47
LOSARTAN POTASSIUM 57 47 27 31
LOSARTAN-HYDROCHLOROTHIAZIDE 55 55 29 73
GLIPIZIDE ER 55 42 29 106
GABAPENTIN 55 46 29 11
METOPROLOL SUCCINATE 53 53 32 17
OXYBUTYNIN CHLORIDE 51 37 33 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 31, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.